Bunk science is influencing the transgender kid boom
Also, Biden's way of avoiding “kids in cages”
Editorial Team
July 14, 2024
Today we’re covering:
🚸 Troubling strategy to avoid “kids in cages” headlines,
🏳️🌈 What’s behind the spike in transgenderism,
And everything else you need to know.
This is a free preview of our member-only weekend newsletters. Start a free 14-day trial for full access.
WHAT WE'RE WATCHING
⚠️ To avoid “kids in cages,” the Biden admin. sent kids to dangerous strangers. Internal government memos reveal that the Biden administration has ignored caseworker concerns about the safety of some homes where unaccompanied migrant children were placed. Many children were sent to homes with histories of criminal activity, as the administration was rushing to house children to avoid “kids in cages” headlines.
📹 The Chinese have been quietly mass-surveilling American roads. In California, Chinese-owned companies have used self-driving cars to drive over 1.8 million miles, highlighting a potential national security risk as they collect large amounts of data about their surroundings. The state program to test self-driving cars has been described as “literally the Wild West” and that “there’s no one in charge.”
🇨🇳 House Republicans are demanding answers over Chinese border crossers. Rep. Chip Roy (R-TX) and 16 other GOP Congressmen are requesting information from Secretary of State Blinken and Homeland Security Secretary Mayorkas on federal deportation policies, particularly regarding illegal migrants from China. This comes as over 30,000 Chinese nationals have illegally entered the United States this year alone.
💸 Sanctuary cities are rolling back their migrant shelter programs. Chicago, Denver, and New York have all been scaling back their migrant shelters due to exorbitant costs and overwhelmed city resources. Migrant programs in these three cities have cost residents over $1 billion, with Mayor Eric Adams going so far as to claim, “This issue will destroy New York City.”
💊 The FTC is suing middlemen over high drug costs. The Federal Trade Commission (FTC) is gearing up to sue several pharmacy benefit managers over their price negotiation tactics, including for critical medications like insulin. After a two-year investigation, the FTC is targeting these companies for allegedly steering patients away from more affordable drug options, thereby manipulating the market to their advantage.